IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,853,914 | -8.8% | 242,843 | +8.4% | 0.00% | 0.0% |
| Q2 2023 | $4,227,766 | +156.3% | 224,047 | -47.8% | 0.00% | – |
| Q1 2023 | $1,649,357 | +171.9% | 429,520 | +251.2% | 0.00% | – |
| Q4 2022 | $606,688 | -76.2% | 122,316 | -77.1% | 0.00% | -100.0% |
| Q3 2022 | $2,551,000 | -11.7% | 533,640 | -16.9% | 0.00% | 0.0% |
| Q2 2022 | $2,889,000 | -26.1% | 642,189 | -21.8% | 0.00% | 0.0% |
| Q1 2022 | $3,907,000 | -36.3% | 820,858 | -0.7% | 0.00% | -50.0% |
| Q4 2021 | $6,136,000 | +13.3% | 826,939 | -13.5% | 0.00% | +100.0% |
| Q3 2021 | $5,418,000 | -16.0% | 955,582 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $6,451,000 | -27.9% | 978,943 | -11.3% | 0.00% | -50.0% |
| Q1 2021 | $8,942,000 | +3.3% | 1,103,795 | -17.8% | 0.00% | 0.0% |
| Q4 2020 | $8,658,000 | +74.3% | 1,342,347 | -2.7% | 0.00% | +100.0% |
| Q3 2020 | $4,967,000 | -21.1% | 1,379,702 | +0.9% | 0.00% | -50.0% |
| Q2 2020 | $6,292,000 | +62.4% | 1,367,870 | +20.4% | 0.00% | +100.0% |
| Q1 2020 | $3,875,000 | -38.9% | 1,136,288 | -8.6% | 0.00% | -50.0% |
| Q4 2019 | $6,345,000 | +118.9% | 1,242,913 | +3.7% | 0.00% | +100.0% |
| Q3 2019 | $2,899,000 | +9.6% | 1,198,125 | -1.7% | 0.00% | 0.0% |
| Q2 2019 | $2,644,000 | -22.6% | 1,218,553 | -3.3% | 0.00% | 0.0% |
| Q1 2019 | $3,416,000 | -46.3% | 1,260,619 | -4.9% | 0.00% | -50.0% |
| Q4 2018 | $6,364,000 | -57.4% | 1,325,791 | -16.0% | 0.00% | -50.0% |
| Q3 2018 | $14,946,000 | -16.9% | 1,578,151 | -14.6% | 0.00% | -20.0% |
| Q2 2018 | $17,983,000 | -4.4% | 1,848,216 | +3.3% | 0.01% | -16.7% |
| Q1 2018 | $18,817,000 | +88.3% | 1,788,639 | +14.7% | 0.01% | +100.0% |
| Q4 2017 | $9,993,000 | -14.4% | 1,558,852 | +2.2% | 0.00% | -25.0% |
| Q3 2017 | $11,672,000 | +4.2% | 1,525,786 | -3.2% | 0.00% | 0.0% |
| Q2 2017 | $11,206,000 | +78.7% | 1,576,158 | -2.7% | 0.00% | +100.0% |
| Q1 2017 | $6,270,000 | +71.8% | 1,620,279 | -9.4% | 0.00% | +100.0% |
| Q4 2016 | $3,649,000 | -8.1% | 1,789,209 | +20.8% | 0.00% | 0.0% |
| Q3 2016 | $3,969,000 | -11.2% | 1,481,117 | +2.0% | 0.00% | -50.0% |
| Q2 2016 | $4,470,000 | -62.7% | 1,451,444 | +3.2% | 0.00% | -60.0% |
| Q1 2016 | $11,981,000 | -38.6% | 1,406,179 | -2.2% | 0.01% | -37.5% |
| Q4 2015 | $19,513,000 | +39.9% | 1,437,982 | -1.0% | 0.01% | +33.3% |
| Q3 2015 | $13,946,000 | -35.1% | 1,452,665 | -2.8% | 0.01% | -25.0% |
| Q2 2015 | $21,500,000 | -14.1% | 1,495,133 | -46.5% | 0.01% | +60.0% |
| Q1 2015 | $25,028,000 | +322.3% | 2,796,506 | +187.8% | 0.01% | +150.0% |
| Q4 2014 | $5,927,000 | -36.1% | 971,606 | +10.9% | 0.00% | -50.0% |
| Q3 2014 | $9,281,000 | +1.7% | 876,418 | +13.8% | 0.00% | 0.0% |
| Q2 2014 | $9,126,000 | -12.7% | 770,123 | +10.1% | 0.00% | 0.0% |
| Q1 2014 | $10,448,000 | +9.0% | 699,783 | +7.1% | 0.00% | 0.0% |
| Q4 2013 | $9,587,000 | +33.2% | 653,517 | +54.5% | 0.00% | +33.3% |
| Q3 2013 | $7,197,000 | +10.4% | 422,881 | +7.6% | 0.00% | 0.0% |
| Q2 2013 | $6,520,000 | – | 393,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |